Axovant Sciences Ltd. (AXON - Free Report) was a big mover last session, as the company saw its shares rise a little above 9% on the day. The upside was driven by the company’s encouraging corporate and financial developments. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 47% in the past one-month time frame.
The company has seen one negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate moved lower over the same timeframe suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Axovant Sciences currently carries a Zacks Rank #3 (Hold).
Axovant Sciences Ltd. Price
A better-ranked stock in the Medical – Biomedical and Genetics industry is Anthera Pharmaceuticals, Inc. (ANTH - Free Report) sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Axovant Sciences Ltd. (AXON - Free Report) was a big mover last session, as the company saw its shares rise a little above 9% on the day. The upside was driven by the company’s encouraging corporate and financial developments. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 47% in the past one-month time frame.
The company has seen one negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate moved lower over the same timeframe suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Axovant Sciences currently carries a Zacks Rank #3 (Hold).
Axovant Sciences Ltd. Price
A better-ranked stock in the Medical – Biomedical and Genetics industry is Anthera Pharmaceuticals, Inc. (ANTH - Free Report) sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ANTH - FREE
Get the latest research report on AXON - FREE